Trial intelligence / Profile preview

Frio Oral Rinse for Gingivitis

NCT00391547Phase 2Completed

Sponsor
Biomedical Development
Start
Oct 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of iodine in gingivitis, sponsored by Biomedical Development. Primary endpoint: Reduction of the Gingival Index values at 12 weeks. Started Oct 2006; status: completed.

02

Drugs

iodine
03

Conditions

gingivitis

Beyond the preview

Go deeper on NCT00391547.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00391547.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call